These increases in Akt‐dependent effects on SREBP‐1c and lipogenic enzyme expression accentuate those induced by increases in hepatic aPKC activity owing to increases in hepatic ceramide levels and hyperinsulinemia acting through IRS‐2/PI3K. The gene discussed is AKT1; the disease is hyperinsulinism.